Journal of Business Ethics 94 (2):211-224 (2010)
Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European Union (EU). Doing so results in an alternative analysis of the struggle between proponents and opponents of DTCA from a CSR perspective, adding an alternative view on this debate.
|Keywords||corporate social responsibility (CSR) pharmaceutical industry direct-to-consumer-advertising (DTCA) consumer safety|
|Categories||categorize this paper)|
References found in this work BETA
Corporate Social Responsibility Theories: Mapping the Territory. [REVIEW]Elisabet Garriga & Domènec Melé - 2004 - Journal of Business Ethics 53 (1-2):51-71.
Corporate Social Responsibility Evolution of a Definitional Construct.Archie B. Carroll - 1999 - Business and Society 38 (3):268-295.
A Bibliometric Analysis of 30 Years of Research and Theory on Corporate Social Responsibility and Corporate Social Performance.Frank G. A. De Bakker, Peter Groenewegen & Frank Den Hond - 2005 - Business and Society 44 (3):283-317.
Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma.David B. Resnik - 2001 - Developing World Bioethics 1 (1):11-32.
The Corporate Social Responsibility of The Pharmaceutical Industry: Idealism Without Illusion and Realism Without Resignation.Klaus M. Leisinger - 2005 - Business Ethics Quarterly 15 (4):577-594.
Citations of this work BETA
Advertisement Disclaimer Speed and Corporate Social Responsibility: “Costs” to Consumer Comprehension and Effects on Brand Trust and Purchase Intention. [REVIEW]Kenneth C. Herbst, Sean T. Hannah & David Allan - 2013 - Journal of Business Ethics 117 (2):297-311.
Similar books and articles
Perceived Organizational Motives and Consumer Responses to Proactive and Reactive CSR.Mark D. Groza, Mya R. Pronschinske & Matthew Walker - 2011 - Journal of Business Ethics 102 (4):639-652.
A Content Analysis of Men and Women in Canadian Consumer Magazine Advertising: Today's Portrayal, Yesterday's Image?Nan Zhou & Mervin Y. T. Chen - 1997 - Journal of Business Ethics 16 (5):485-495.
Social Responsibility, Social Capital, and Corporate Competitive Advantage in Transitional China.Junwei Shi, Haiyan Fu & Lijun Hu - 2007 - International Corporate Responsibility Series 3:377-394.
The Advertising Effects of Corporate Social Responsibility on Corporate Reputation and Brand Equity: Evidence From the Life Insurance Industry in Taiwan. [REVIEW]Ker-Tah Hsu - 2012 - Journal of Business Ethics 109 (2):189-201.
Consumer Perceptions of the Antecedents and Consequences of Corporate Social Responsibility.Andrea J. S. Stanaland, May O. Lwin & Patrick E. Murphy - 2011 - Journal of Business Ethics 102 (1):47-55.
Role of Socioeconomic Status on Consumers' Attitudes Towards DTCA of Prescription Medicines in Australia.Betty B. Chaar & Johnson Lee - 2012 - Journal of Business Ethics 105 (4):447-460.
Consumer Believability of Information in Direct-to-Consumer (DTC) Advertising of Prescription Drugs.Richard F. Beltramini - 2005 - Journal of Business Ethics 63 (4):333 - 343.
Is Banning Direct to Consumer Advertising of Prescription Medicine Justified Paternalism?Uvonne Lau - 2005 - Journal of Bioethical Inquiry 2 (2):69-74.
Added to index2009-11-23
Total downloads51 ( #101,114 of 2,158,189 )
Recent downloads (6 months)5 ( #65,193 of 2,158,189 )
How can I increase my downloads?